top of page
Industry Update
1761202175sNF69.gif

The disease burden of mental disorders has become increasingly relevant as this causes a high degree of individual and social suffering, whereas mood and anxiety disorders are commonly involved. Previous pooled analysis suggested that the lifetime p...

Oct 24, 2025

Hodgkin lymphoma (HL) is a rare B-cell lymphatic malignancy distinguished by its unique histological, immunophenotypic, and clinical characteristics 1,2 . According to the 2022 Hong Kong Cancer Registry data, HL accounts for ~3% of all haematologica...

Aug 14, 2025

Hyperphosphataemia is a hallmark of chronic kidney disease–mineral and bone disorder (CKD-MBD), contributing significantly to vascular calcification, cardiovascular morbidity, and mortality in dialysis patients 1-2 . Effective management of el...

Aug 14, 2025

Chronic hepatitis B (CHB) is one of the leading causes of hepatocellular carcinoma (HCC), cirrhotic complications and liver-related death worldwide. Therefore, controlling chronic hepatitis B virus (HBV) infection is crucial for reducing the risk of...

Apr 11, 2025

Multiple myeloma (MM) is one of the most common haematological malignancies with a global incidence ranging from 0.5 to 5 per 100,000 1 . It is characterised by the monoclonal proliferation of malignant plasma cells in the bone marrow, leading to da...

Aug 14, 2025

The elevation of low-density lipoprotein cholesterol (LDL-C) is a key aspect of dyslipidaemia and is associated with an increased cardiovascular risk, especially in atherosclerotic cardiovascular disease (ASCVD). While numerous studies advocate the ...

Jun 13, 2025

POPULAR STORY

The Immune Reset Revolution: CAR T-Cell Therapy Takes Centre Stage at EULAR 2026

Dr. Feng Xue

​

A Silent Killer No More: How New Discoveries Are Changing Pancreatic Cancer Outcomes

Dr. Feng Xue

​

Hope in Motion: Clinical Progress and Social Support for Parkinson’s

Andrew Chan

​

Uncovering the Tricks of the Silent Thief of Sight

Dr. Roy Lau

Dec 19, 2024

What’s New in Coronary Artery Disease?

Dr. Roy Lau

Aug 20, 2024

Challenges and Strategies for Managing CHB Patients with Co-morbidities

Dr. Roy Lau

Jun 21, 2024

bottom of page